Ban on miscarriage management, abortion drug still possible

Sen. Blumenthal and Dr. Nancy Stanwood spoke about the on-going threat to ban the abortion pill.
Published: Apr. 24, 2023 at 8:31 AM EDT|Updated: Apr. 24, 2023 at 12:47 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

NEW HAVEN, CT (WFSB) - Despite a decision late last week to temporarily continue the use of a miscarriage management and abortion drug, a ban remains in the realm of possibility.

Advocates and Connecticut Sen. Richard Blumenthal participated in a news conference to talk about the impact a potential ban on mifepristone would have on the women who need it.

The news conference happened at 9 a.m. at Planned Parenthood of Southern New England in New Haven.

A doctor from Planned Parenthood said mixing politics with medicine has the potential to upend the country’s drug approval process.

“The Texas ruling is an attempt to turn back the clock on safe medical care, to reek havoc on safe medical care and delivery and to deny patients of the care that they need,” said Dr. Nancy Stanwood, chief medical officer, Planned Parenthood of Southern New England.

While the U.S. Supreme Court on Friday night temporarily allowed continued access to the medication, Blumenthal said the case now goes back to a federal circuit court.

“The respite is only temporary,” Blumenthal said. “We are not out of the woods by any means.”

Mifepristone has been approved for use in the U.S. since 2000 and more than 5 million people have used it. Mifepristone is used in combination with a second drug, misoprostol, in more than half of all abortions in the U.S.

The Associated Press reported that the court’s action Friday almost certainly will leave access to mifepristone unchanged at least into next year, as appeals play out, including a potential appeal to the high court. The next stop for the case is at the New Orleans-based U.S. Court of Appeals for the 5th Circuit, which has set arguments in the case for May 17.